Shuttle Pharmaceuticals Holdings (SHPH) Depreciation and Depletion (2021 - 2025)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Depreciation and Depletion of $1008.0 in Q3 2025, up 202.96% quarter-over-quarter from -$979.0 in Q2 2025, and up 27.11% on a YoY basis from $793.0 in Q3 2024.
Shuttle Pharmaceuticals Holdings (SHPH) Depreciation and Depletion (2021 - 2025) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $1008.0 for Q3 2025.
- In Q3 2025, Depreciation and Depletion rose 27.11% year-over-year to $1008.0; the TTM figure through Sep 2025 stood at $2833.0 (down 49.86% YoY), while the FY2024 annual figure was $5463.0, down 19.79% from the prior year.
- Depreciation and Depletion was $1008.0 for Q3 2025 at Shuttle Pharmaceuticals Holdings, up from -$979.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $2168.0 in Q4 2021 to a low of -$979.0 in Q2 2025.
- Historically, Depreciation and Depletion has averaged $1340.7 across 5 years, with a median of $1485.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Depreciation and Depletion soared 33.27% in 2023, then tumbled 201.77% in 2025.
- A 5-year view of Depreciation and Depletion shows it stood at $2168.0 in 2021, then tumbled by 31.37% to $1488.0 in 2022, then jumped by 33.27% to $1983.0 in 2023, then fell by 9.43% to $1796.0 in 2024, then slumped by 43.88% to $1008.0 in 2025.
- The last three Depreciation and Depletion figures came in at $1008.0 (Q3 2025), -$979.0 (Q2 2025), and $1008.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 2.32 Mn | 1.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,008.00 |
| Sep 30, 2025 | 1,008.00 |
| Jun 30, 2025 | -979.00 |
| Jun 30, 2025 | -979.00 |
| Mar 31, 2025 | 1,008.00 |
| Mar 31, 2025 | 1,008.00 |
| Dec 31, 2024 | 1,796.00 |
| Dec 31, 2024 | 1,796.00 |
| Sep 30, 2024 | 793.00 |
| Sep 30, 2024 | 793.00 |
| Jun 30, 2024 | 962.00 |
| Jun 30, 2024 | 962.00 |
| Mar 31, 2024 | 1,912.00 |
| Mar 31, 2024 | 1,912.00 |
| Dec 31, 2023 | 1,983.00 |
| Dec 31, 2023 | 1,983.00 |
| Sep 30, 2023 | 1,858.00 |
| Sep 30, 2023 | 1,858.00 |
| Jun 30, 2023 | 1,482.00 |
| Jun 30, 2023 | 1,482.00 |